Back to Search
Start Over
Commentary: Oncologic drugs in patients with organ dysfunction: a summary
- Source :
- The oncologist. 12(9)
- Publication Year :
- 2007
-
Abstract
- Learning Objectives After completing this course, the reader will be able to: Describe the currently recommended dose adjustments for common chemotherapeutics in oncology patients with organ dysfunction.Explain the rationale for using phase I dose-escalation studies to determine appropriate chemotherapy dosing in patients with organ dysfunction.Discuss the limitations of the currently available studies to guide chemotherapy dose adjustment in patients with organ dysfunction. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
- Subjects :
- Cancer Research
medicine.medical_specialty
Antimetabolites, Antineoplastic
Topoisomerase Inhibitors
medicine.medical_treatment
education
Antineoplastic Agents
Kidney
Pharmacokinetics
medicine
Humans
Dosing
Prospective Studies
Intensive care medicine
Prospective cohort study
Chemotherapy
Antibiotics, Antineoplastic
business.industry
Liver Diseases
Organ dysfunction
Case-control study
Cancer
medicine.disease
Antineoplastic Agents, Phytogenic
Oncology
Liver
Case-Control Studies
Toxicity
Kidney Diseases
medicine.symptom
business
Subjects
Details
- ISSN :
- 10837159
- Volume :
- 12
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- The oncologist
- Accession number :
- edsair.doi.dedup.....124aaf7df0af75815d3ccac19f406f13